You are here

Seven Day Slim Capsules

Seven Day Slim capsules pose a serious risk to your health and should not be taken.

8 April 2020

Seven Day Slim capsules pose a serious risk to your health and should not be taken.

The Therapeutic Goods Administration (TGA) has tested a product labelled Seven Day Slim and found that:

  • Seven Day Slim capsules contain the undeclared substances Diclofenac and Lidocaine

Lidocaine is an anesthetic medication. The dosage form of Lidocaine found in this product corresponds to Schedule 4 (S4) Prescription Only Medicine.

Diclofenac is a non-steriodal anti-inflammatory drug (NSAID) and is a Schedule 3 Pharmacist-Only Medicine in this preparation.

The supply of Seven Day Slim capsules containing the undisclosed Diclofenac and Lidocaine is illegal.

Seven Day Slim capsules have not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA.

Information for consumers

  • Stop taking Seven Day Slim capsules and take any remaining capsules to your local pharmacy for safe disposal.
  • If you have any concerns arising from your use of this product, consult your health care practitioner.

Action the TGA is taking

The TGA is working with the Australian Border Force (ABF) to help stop future shipments of Seven Day Slim capsules from entering Australia.

If these capsules are found at the border by the ABF they will be seized and destroyed.

The TGA is advising consumers to exercise extreme caution when purchasing medicines from unknown overseas Internet sites and has produced a short video on the risks associated with buying medicines and medical devices online. Products purchased over the Internet:

  • may contain undisclosed and potentially harmful ingredients
  • may not meet the same standards of quality, safety and efficacy as those approved by the TGA for supply in Australia.

Report counterfeit medicines and medical devices

If you are worried about counterfeit medicines or medical devices, and want to report an issue, you can report the matter to the TGA:

Phone: 1800 020 653

Online: Report a perceived breach of the Therapeutic Goods Act or questionable practices relating to therapeutic products

Email: